Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?

To: Myron David Kor who wrote (712)	6/5/1999 5:34:00 PM
From: Lel H	Respond to of 1139

I don't think the company would use a PaineWebber conference to announce clinical trial results. And even if they were going to use the conference as a forum, I think they would send either Mike Gallatin or Tom St. John to make the announcement and answer questions. I'm not holding my breath for any real news.

To: Myron David Kor who wrote (712)	6/6/1999 2:14:00 PM
From: RCMac	Respond to of 1139

"They [Lilly at analysts meeting] discussed their pipeline . . .. IC351 for erectile dysfunction will be submitted [NDA] in 2001." from Will's Daily Pharmaceutical Commentary on Labpuppy, for 6/4/99: labpuppy.com